Sex Hormone Levels and Risk of Cardiovascular Events in Postmenopausal Women
- 7 October 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 108 (14) , 1688-1693
Abstract
Background— Despite diffuse effects of sex hormones on the cardiovascular system, few prospective studies have examined the relationship of plasma androgens and estrogens with risk of cardiovascular disease (CVD) in postmenopausal women. Methods and Results— A nested case-control study was performed among women in the Women’s Health Study. Two hundred women who developed CVD were matched 1:1 by age, smoking, and postmenopausal hormone therapy (HT) to controls who remained free of CVD. We measured testosterone, estradiol, and sex hormone binding globulin (SHBG) levels and calculated free androgen index (FAI), free estradiol index, and the FAI/free estradiol index ratio. Results were stratified by HT use. Among HT nonusers, cases had significantly higher androgen profiles (higher median FAI and lower SHBG levels) than controls. After adjustment for age, smoking, use of aspirin, vitamin E, and alcohol, family history of myocardial infarction, and physical activity, nonusers in the lowest SHBG quartile had an OR of 2.25 (95% CI, 1.03 to 4.91) for CVD, and there were significant trends across FAI quartiles ( P for trend=0.03). Additional adjustment for body mass index, hypertension, diabetes, and elevated cholesterol eliminated associations with SHBG and FAI. Among women using HT, no significant differences in hormones or SHBG were observed among women who developed CVD and controls. Conclusions— Among HT nonusers, lower SHBG and higher FAI levels were noted among postmenopausal women who developed CVD events, but this was not independent of body mass index and other cardiovascular risk factors. Estradiol levels were not associated with risk of CVD in HT users or nonusers.Keywords
This publication has 19 references indexed in Scilit:
- Relation of serum levels of sex hormone binding globulin to coronary heart disease in postmenopausal womenThe American Journal of Cardiology, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- The Protective Effects of Estrogen on the Cardiovascular SystemNew England Journal of Medicine, 1999
- Endogenous Androgens and Carotid Intimal-Medial Thickness in WomenThe Journal of Clinical Endocrinology & Metabolism, 1999
- Endogenous Hormones and the Risk of Hip and Vertebral Fractures among Older WomenNew England Journal of Medicine, 1998
- Sex Hormones and DHEA-SO4 in Relation to Ischemic Heart Disease Mortality in Diabetic subjects: The Wisconsin Epidemiologic Study of Diabetic RetinopathyDiabetes Care, 1996
- Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal womenBMJ, 1995
- Body fat distribution and its association with metabolic and hormonal risk factors in women with angiographically assessed coronary artery disease. Evidence for the presence of a metabolic syndromeAtherosclerosis, 1994
- Sex Hormone Binding Globulin: Origin, Function and Clinical SignificanceAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1990
- Radioimmunoassay of plasma estrogensSteroids, 1971